glp-1 treatment for newly diagnosed diabetes guidelines The pharmacological management of Type 2 Diabetes, adapted from ADA 2025 guidelines, focusing on initiation and intensification based on patient comorbidities and glycemic control Diabetes treatment - Gan &

Once Tirzepatide was stopped, the patients symptoms dramatically improved and there was improvement also demonstrated on CT imaging

A Phase 1, randomised, placebo-controlled, double-blind study was comprised of three parts: a single-ascending dose (SAD

Notably, the diversification of gut microbiota resulting from metformin treatment was observed following oral administration in mice, a phenomenon not replicated with intraperitoneal injection (Wu H

As weight decreases and metabolic health improves, physical activity becomes easier and more enjoyable

Gastrointestinal issues, including nausea, vomiting, diarrhea and headaches, are commonly reported side effects of GLP-1s, according to the Mayo Clinic